Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II–III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance)
Titel:
Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II–III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance)
Auteur:
Golshan, Mehra Cirrincione, Constance T. Sikov, William M. Carey, Lisa A. Berry, Donald A. Overmoyer, Beth Henry, Nora L. Somlo, George Port, Elisa Burstein, Harold J. Hudis, Clifford Winer, Eric Ollila, David W.